| Application no. and date | 20710607.1 (espacenet) (Federated) (European Patent Register), 20200226 | | Patent/reg. no. and date | DK/EP 3930715, 20240508 | | Publication date | 20220105 | | Priority no. and date | US 201962811009 P, 20190227 | | EP pub. no. and date |
EP 3930715 20220105 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE,
Fraunhofer-Gesellschaft zur Förderung
der angewandten Forschung e.V., Hansastr. 27c
80686 München, DE | | Applicant ref. no. | 1704696 | | Inventor | COUSENS, Leslie, AstraZeneca Pharmaceuticals LP
35 Gatehouse Drive
Waltham, Massachusetts 02451, US,
NIVENS, Chad, AstraZeneca Pharmaceuticals LP
35 Gatehouse Drive
Waltham, Massachusetts 02451, US,
ESCOTT, Katherine Jane, AstraZeneca UK Limited
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA, GB,
MONKLEY, Susan, AstraZeneca AB
Pepparedsleden 1
Mölndal, SE,
PRASSE, Antje, Fraunhofer-Gesellschaft zur Forderung der
Angewandten Forschung E.V.
Hansastraße 27c
München, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/4412 (2006.01) , A61K 31/496 (2006.01) , A61K 45/06 (2006.01) , A61P 11/00 (2006.01) | | Title | SARACATINIB TIL ANVENDELSE TIL BEHANDLING AF IDIOPATISK LUNGEFIBROSE | | Int. application no. | IB2020051642 | | Int. publication no. | WO2020174420 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
